EXAS vs MLCI · rev $2.76B vs rev $53.6M
EXACT Sciences Corporation (EXAS) versus Mount Logan Capital Inc. Common Stock (MLCI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Mount Logan Capital Inc. Common Stock (MLCI) is a asset management company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MLCI revenue for 2025-12-31 was $53.6M. Net income was -$60.8M. Revenue was up 7.6% from 2024-12-31 to 2025-12-31. MLCI currently screens at market cap $30.8M.
EXAS currently screens at market cap $20.03B. MLCI currently screens at market cap $30.8M.
Not investment advice. Open the EXAS and MLCI stock pages for the full models.
Not investment advice.